Clinical Trial Update: Phase IIb Study Evaluating Immunogenic Chemotherapy Combined With Ipilimumab and Nivolumab in Breast Cancer [Phase 2]

View source ↗

Summary

A completed Phase IIb trial evaluated immunogenic chemotherapy in combination with ipilimumab and nivolumab for breast cancer, including metastatic breast cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• OPDIVO (nivolumab)
• Yervoy (ipilimumab)

Snippet

Sponsor: Oslo University Hospital | Conditions: Breast Cancer, Hormone Receptor Positive Tumor | Phase 2 | Status: COMPLETED